(CME) CME - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12572Q1058

CME: Futures, Options, Commodities, Securities, Data, Clearing

CME Group Inc. stands as a titan in the financial derivatives sector, operating some of the globes most substantial futures and options contract markets. As one of the largest derivatives exchanges, it provides a vast array of products spanning interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, and more. This extensive offerings allow for precise risk management and investment strategies across various asset classes.

Headquartered in Chicago, CME Groups legacy traces back to 1898, evolving from the Chicago Mercantile Exchange. Its services extend beyond trading, encompassing critical functions like clearing, settling, and guaranteeing contracts. This role is vital for maintaining market integrity and facilitating smooth transactions. Additionally, the company offers trade processing and risk mitigation services, essential for institutional risk management.

CME Group serves a diverse clientele, including professional traders, financial institutions, and institutional investors. Corporations, governments, and central banks also rely on their services for hedging and investment purposes. Their market data services provide real-time and historical data, crucial for informed decision-making in trading and analysis.

Financially, CME Group boasts a market capitalization of over $90 billion, with key metrics including a P/E ratio of approximately 25.89 and a forward P/E of 23.81. These figures underscore its stability and growth prospects in the financial sector. For more details, visit their website at https://www.cmegroup.com.

Additional Sources for CME Stock

CME Stock Overview

Market Cap in USD 91,449m
Sector Financial Services
Industry Financial Data & Stock Exchanges
GiC Sub-Industry Financial Exchanges & Data
IPO / Inception 2002-12-06

CME Stock Ratings

Growth 5y 74.8%
Fundamental 72.6%
Dividend 76.2%
Rel. Strength Industry 2.2
Analysts 3.33/5
Fair Price Momentum 282.04 USD
Fair Price DCF 230.62 USD

CME Dividends

Dividend Yield 12m 4.48%
Yield on Cost 5y 8.67%
Annual Growth 5y 12.00%
Payout Consistency 95.5%

CME Growth Ratios

Growth Correlation 3m 91.1%
Growth Correlation 12m 83.5%
Growth Correlation 5y 74.3%
CAGR 5y 16.35%
CAGR/Max DD 5y 0.52
Sharpe Ratio 12m 1.56
Alpha 19.81
Beta -0.10
Volatility 18.90%
Current Volume 1935.7k
Average Volume 20d 2144.6k
What is the price of CME stocks?
As of March 16, 2025, the stock is trading at USD 258.68 with a total of 1,935,748 shares traded.
Over the past week, the price has changed by +1.61%, over one month by +5.90%, over three months by +12.93% and over the past year by +23.36%.
Is CME a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, CME (NASDAQ:CME) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 72.64 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CME as of March 2025 is 282.04. This means that CME is currently overvalued and has a potential downside of 9.03%.
Is CME a buy, sell or hold?
CME has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold CME.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 10
  • Sell: 3
  • Strong Sell: 0
What are the forecast for CME stock price target?
According to ValueRays Forecast Model, CME CME will be worth about 304.6 in March 2026. The stock is currently trading at 258.68. This means that the stock has a potential upside of +17.75%.
Issuer Forecast Upside
Wallstreet Target Price 254.6 -1.6%
Analysts Target Price 242.4 -6.3%
ValueRay Target Price 304.6 17.8%